Novozymes A/S (NVZMY) News Today $71.64 -0.69 (-0.95%) As of 06/30/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock NVZMY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period NVZMY Novozymes A/S - Seeking AlphaJune 24, 2025 | seekingalpha.comNovozymes A/S (OTCMKTS:NVZMY) Hits New 12-Month High - Should You Buy?June 16, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest Down 60.0% in MayJune 14, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Reaches New 1-Year High - Here's WhyJune 9, 2025 | marketbeat.comNovonesis A/S (OTC:NVZMY) Stock Price Up 1.8% - Should You Buy?June 7, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Above 50 Day Moving Average - What's Next?June 6, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Reaches New 12-Month High - Here's What HappenedJune 3, 2025 | marketbeat.comNovonesis: Industry Leader With Defensive Characteristics And Solid GrowthJune 1, 2025 | seekingalpha.comShort Interest in Novozymes A/S (OTCMKTS:NVZMY) Drops By 58.8%May 30, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Shares Pass Above 50 Day Moving Average - Time to Sell?May 24, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Shares Pass Above 50 Day Moving Average - Here's What HappenedMay 16, 2025 | marketbeat.comNovonesis A/S (NVZMY)May 14, 2025 | finance.yahoo.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Passes Above 50-Day Moving Average - Here's What HappenedMay 8, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest UpdateApril 29, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Stock Crosses Above Fifty Day Moving Average - Time to Sell?April 24, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Sees Significant Growth in Short InterestApril 16, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Below 200 Day Moving Average - Here's What HappenedApril 13, 2025 | marketbeat.comNovonesis A/S (OTC:NVZMY) Trading 6.4% Higher - What's Next?April 13, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Below Two Hundred Day Moving Average - Here's WhyApril 4, 2025 | marketbeat.comNovonesis price target lowered to DKK 490 from DKK 500 at BarclaysMarch 30, 2025 | markets.businessinsider.comNovonesis A/S (OTC:NVZMY) Stock Price Down 0.9% - Here's WhyMarch 20, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Stock Crosses Below Two Hundred Day Moving Average - What's Next?March 19, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) to Issue Dividend Increase - $0.38 Per ShareMarch 12, 2025 | marketbeat.comInvitation to the Annual General MeetingMarch 11, 2025 | finance.yahoo.comNovozymes A/S (OTCMKTS:NVZMY) Stock Passes Below 200-Day Moving Average - Should You Sell?March 11, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?March 2, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Stock Price Passes Above 50-Day Moving Average - Should You Sell?February 21, 2025 | marketbeat.comNovonesis to acquire dsm-firmenich’s share of the Feed Enzyme AllianceFebruary 12, 2025 | finance.yahoo.comNovonesis (Novozymes) B ADRFebruary 8, 2025 | morningstar.comMNovonesis: Still Too ExpensiveFebruary 6, 2025 | seekingalpha.comNovozymes A/S (OTCMKTS:NVZMY) Stock Price Crosses Below 200 Day Moving Average - Here's WhyFebruary 4, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?January 25, 2025 | marketbeat.comShort Interest in Novozymes A/S (OTCMKTS:NVZMY) Rises By 680.4%January 13, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Shares Cross Below 200 Day Moving Average - Here's WhyJanuary 3, 2025 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Short Interest Up 1,020.0% in DecemberDecember 26, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Below 50 Day Moving Average - Here's What HappenedDecember 20, 2024 | marketbeat.comNovonesis added to European Conviction List at Goldman SachsDecember 2, 2024 | markets.businessinsider.comNovozymes A/S (OTCMKTS:NVZMY) Upgraded by Barclays to Strong-Buy RatingNovember 20, 2024 | marketbeat.comNovonesis Reports Strong Q3 Growth in 2024November 9, 2024 | markets.businessinsider.comNovonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade)November 8, 2024 | seekingalpha.comNovozymes A/S (OTCMKTS:NVZMY) Stock Passes Below 50 Day Moving Average - What's Next?November 5, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Stock Rating Lowered by CitigroupOctober 17, 2024 | marketbeat.comShort Interest in Novozymes A/S (OTCMKTS:NVZMY) Drops By 73.5%October 10, 2024 | marketbeat.comBerenberg Bank Upgrades Novozymes A/S (OTCMKTS:NVZMY) to "Strong-Buy"September 26, 2024 | marketbeat.comNovozymes A/S (OTCMKTS:NVZMY) Sets New 1-Year High After Dividend AnnouncementAugust 30, 2024 | marketbeat.comWhat Wall Street expects from Novozymes A-S (B)'s earningsAugust 27, 2024 | markets.businessinsider.comNovozymes A-S (B) Un earnings: here's what to expectAugust 27, 2024 | markets.businessinsider.comNovozymes A/S B (NSISb)July 19, 2024 | investing.comNovozymes A/S (NSISBC.XC)July 19, 2024 | finance.yahoo.comNovozymes A/S (OTCMKTS:NVZMY) Sees Large Increase in Short InterestJune 30, 2024 | marketbeat.com Get Novozymes A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter. Email Address NVZMY Media Mentions By Week NVZMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVZMY News Sentiment▼0.000.58▲Average Basic Materials News Sentiment NVZMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVZMY Articles This Week▼11▲NVZMY Articles Average Week Get Novozymes A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVZMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sherwin-Williams News Today Ecolab News Today Givaudan News Today SIKA News Today PPG Industries News Today International Flavors & Fragrances News Today Symrise News Today RPM International News Today Toray Industries News Today Sociedad Quimica y Minera News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NVZMY) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novozymes A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novozymes A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
